Literature DB >> 3593621

Neurogenic hypertension associated with an excessively high excretion rate of catecholamine metabolites.

C Funck-Brentano, J Y Pagny, J Menard.   

Abstract

A 60 year old hypertensive patient suffered several cerebral infarctions. A phaeochromocytoma was suspected because the excretion rates of vanillylmandelic acid and its methoxy derivatives were raised and the patient had hypertensive crises. No tumour was found, however, by 131mI-iodobenzylguanidine scintigraphy and computed tomography of the abdomen. Moreover, the enhanced orthostatic plasma catecholamine response suggested that the high excretion rates of catecholamine metabolites were more likely to be caused by the syndrome of raised catecholamines after cerebrovascular accidents than a phaeochromocytoma. A phaeochromocytoma should not be diagnosed within several months of cerebral infarction without first excluding the possibility of a hyperadrenergic state induced by cerebral infarction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593621      PMCID: PMC1277206          DOI: 10.1136/hrt.57.5.487

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

2.  Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage.

Authors:  J S Meyer; E Stoica; I Pascu; K Shimazu; A Hartmann
Journal:  Brain       Date:  1973-06       Impact factor: 13.501

3.  Pseudopheochromocytoma.

Authors:  O Kuchel
Journal:  Hypertension       Date:  1985 Jan-Feb       Impact factor: 10.190

4.  A syndrome resembling pheochromocytoma following a stroke. Report of a case.

Authors:  R M Mazey; T A Kotchen; C B Ernst
Journal:  JAMA       Date:  1974-10-28       Impact factor: 56.272

5.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; D G Vidt; R W Gifford
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

6.  Catecholamine urinary excretion in cerebrovascular accidents.

Authors:  E Stoica; O Enulescu; C Caloinescu
Journal:  Neurol Psychiatr (Bucur)       Date:  1977 Oct-Dec

7.  Distribution of metanephrine and normetanephrine in various animals and their analysis in diverse biologic material.

Authors:  A H Anton; D F Sayre
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

8.  The lack of normal catecholamine responses in patients with pheochromocytomas.

Authors:  H H Newsome
Journal:  Surgery       Date:  1983-12       Impact factor: 3.982

9.  Prazosin in the diagnosis and treatment of pheochromocytoma.

Authors:  J M Wallace; D P Gill
Journal:  JAMA       Date:  1978-12-15       Impact factor: 56.272

10.  [Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)].

Authors:  P F Plouin; P Degoulet; A Tugayé; M B Ducrocq; J Ménard
Journal:  Nouv Presse Med       Date:  1981-03-07
View more
  1 in total

1.  Pattern of elevation of urine catecholamines in intracerebral haemorrhage.

Authors:  G F Hamann; M Strittmatter; K H Hoffmann; G Holzer; M Stoll; T Keshevar; R Moili; K Wein; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.